Results from Phase 3 KEYNOTE-966 to be presented at AACR 2023 Annual Meeting during Clinical Trials Plenary Session, included in official meeting press program and published simultaneously in The Lancet RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the Phase 3 KEYNOTE-966 trial … [Read more…]

PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune conditions Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology RAHWAY, N.J. & SAN DIEGO–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. (“Prometheus”) … [Read more…]

– Phase 3 Clinical Trial Demonstrated the Safety Profile of Veklury in Patients with Severe Renal Impairment – – Real-World Evidence Demonstrated Veklury Reduced COVID-19- Associated Mortality and Readmission Rates in Immunocompromised Patients Across All Variants of Concern, Including Omicron – – Gilead Presents Positive Phase 1 Data for its Investigational Oral COVID-19 Antiviral Treatment, … [Read more…]

MAPLEWOOD, N.J.–(BUSINESS WIRE)–#danbrotlabiancaproperties–The Resource Home Show, a home improvement trade show, returns after a three plus year hiatus to connect regional homeowners and home design enthusiasts with an eclectic arsenal of home improvement professionals. Specialists spanning a broad cross-section of fields including interior design, architecture, restoration, home maintenance, pools and landscapes, solar, art installation, home … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#COVID19–Amid reports that pharmaceutical CEOs are lobbying the Group of Seven (G7) to protect intellectual property rights in the World Health Organization’s pandemic accord, AIDS Healthcare Foundation urges G7 leaders and other WHO Member States to ensure the world will have access to lifesaving medicines via widespread production in the event of another … [Read more…]

NEW YORK–(BUSINESS WIRE)–Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI) a technology company transforming the company health plan for employers that self-fund their healthcare, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by … [Read more…]

TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2022 fourth quarter and year end operational and financial results after market hours on April 17, 2023. FOURTH QUARTER AND YEAR END 2022 CONFERENCE CALL DETAILS: Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a … [Read more…]

EL SEGUNDO, Calif.–(BUSINESS WIRE)–The Beachbody Company, Inc. (NYSE: BODY) (the “Company” or “Beachbody”), a leading subscription health and wellness company, today announced the completion of a competitive review of independent registered public accounting firms for the year ending December 31, 2023, whereby the Company invited several firms to participate in the process, including its current … [Read more…]

LONDON–(BUSINESS WIRE)–#advancedcirculatorysupport–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced that Damien McDonald has resigned as Chief Executive Officer. Effective immediately, Chair of the Board William A. Kozy is appointed interim CEO to help the executive leadership team maintain the focus on growth and profitability. The Board has retained a leading … [Read more…]

TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter 2023 financial results on Wednesday, May 10, 2023 at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. … [Read more…]